Esperovax

About:

Esperovax is a biotechnology company based in Plymouth, MI.

Top Investors: Michigan Rise, Tech Startup Stabilization Fund, BLUE KNIGHT

Description:

Esperovax is a biotechnology company specializing in a unique, proprietary platform that produces and delivers targeted mRNA oral biologic medicines.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plymouth, Minnesota, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)esperovax.com

Founders:

David O'Hagan, Roger S. Newton, Savita Nikam

Number of Employees:

11-50

Last Funding Date:

2023-10-03

IPO Status:

Private

Industries: